Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1063

1.

Evolution of pathologic T-cell subsets in atopic dermatitis from infancy to adulthood.

Czarnowicki T, He H, Canter T, Han J, Lefferdink R, Erickson T, Rangel S, Kameyama N, Kim HJ, Pavel AB, Estrada Y, Krueger JG, Paller AS, Guttman-Yassky E.

J Allergy Clin Immunol. 2019 Oct 15. pii: S0091-6749(19)31319-3. doi: 10.1016/j.jaci.2019.09.031. [Epub ahead of print]

PMID:
31626841
2.

Increased cardiovascular and atherosclerosis markers in blood of older atopic dermatitis patients.

He H, Li R, Choi S, Zhou L, Pavel A, Estrada YD, Krueger JG, Guttman-Yassky E.

Ann Allergy Asthma Immunol. 2019 Oct 14. pii: S1081-1206(19)31294-3. doi: 10.1016/j.anai.2019.10.013. [Epub ahead of print]

PMID:
31622668
3.

Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications.

Krueger J, Rudd CE, Taylor A.

Semin Immunol. 2019 Apr;42:101295. doi: 10.1016/j.smim.2019.101295. Review.

PMID:
31604533
4.

Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.

Guttman-Yassky E, Diaz A, Pavel AB, Fernandes M, Lefferdink R, Erickson T, Canter T, Rangel S, Peng X, Li R, Estrada Y, Xu H, Krueger JG, Paller AS.

JAMA Dermatol. 2019 Oct 9. doi: 10.1001/jamadermatol.2019.2983. [Epub ahead of print]

PMID:
31596431
5.

IL-17C is Elevated in Lesional Tissue of Hidradenitis Suppurativa.

Navrazhina K, Frew JW, Krueger JG.

Br J Dermatol. 2019 Sep 26. doi: 10.1111/bjd.18556. [Epub ahead of print]

PMID:
31556100
6.

Lymphocyte subset at time of Epstein-Barr viremia post-allogeneic hematopoietic stem cell transplantation in children may predict development of post-transplant lymphoproliferative disease: CD8:CD20 ratio as a sensitive predictor.

Althubaiti S, Ali S, Renzi S, Krueger J, Chiang KY, Schechter T, Punnett A, Ali M.

Pediatr Transplant. 2019 Sep 8:e13574. doi: 10.1111/petr.13574. [Epub ahead of print]

PMID:
31496046
7.

Comparison between intermittent and continuous leukapheresis protocols for autologous hematopoietic stem cell collections in children.

Ali S, Chiang KY, Even-Or E, Di Mola M, Schechter T, Ali M, McDougall E, Svajger G, Licht C, Krueger J.

J Clin Apher. 2019 Aug 19. doi: 10.1002/jca.21741. [Epub ahead of print]

PMID:
31424127
8.

Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis.

Sakurai K, Dainichi T, Garcet S, Tsuchiya S, Yamamoto Y, Kitoh A, Honda T, Nomura T, Egawa G, Otsuka A, Nakajima S, Matsumoto R, Nakano Y, Otsuka M, Iwakura Y, Grinberg-Bleyer Y, Ghosh S, Sugimoto Y, Guttman-Yassky E, Krueger JG, Kabashima K.

J Allergy Clin Immunol. 2019 Oct;144(4):1036-1049. doi: 10.1016/j.jaci.2019.06.019. Epub 2019 Aug 1.

PMID:
31378305
9.

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.

Pavel AB, Song T, Kim HJ, Del Duca E, Krueger JG, Dubin C, Peng X, Xu H, Zhang N, Estrada YD, Denis L, Rao N, Gupta S, Zammit DJ, Bissonnette R, Guttman-Yassky E.

J Allergy Clin Immunol. 2019 Oct;144(4):1011-1024. doi: 10.1016/j.jaci.2019.07.013. Epub 2019 Jul 26.

PMID:
31356921
10.

Public Health Law Strategies for Suicide Prevention Using the Socioecological Model.

Cerulli C, Winterfeld A, Younger M, Krueger J.

J Law Med Ethics. 2019 Jun;47(2_suppl):31-35. doi: 10.1177/1073110519857312.

PMID:
31298117
11.

Interleukin-1 receptor accessory proteins are required for normal homeostatic responses to sleep deprivation.

Nguyen J, Gibbons CM, Dykstra-Aiello C, Ellingsen R, Koh KMS, Taishi P, Krueger JM.

J Appl Physiol (1985). 2019 Sep 1;127(3):770-780. doi: 10.1152/japplphysiol.00366.2019. Epub 2019 Jul 11.

PMID:
31295066
12.

A systematic review and critical evaluation of immunohistochemical associations in hidradenitis suppurativa.

Frew JW, Hawkes JE, Krueger JG.

Version 2. F1000Res. 2018 Dec 11 [revised 2019 Jan 1];7:1923. doi: 10.12688/f1000research.17268.2. eCollection 2018.

13.

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.

Reich K, Gooderham M, Thaçi D, Crowley JJ, Ryan C, Krueger JG, Tsai TF, Flack M, Gu Y, Williams DA, Thompson EHZ, Paul C.

Lancet. 2019 Aug 17;394(10198):576-586. doi: 10.1016/S0140-6736(19)30952-3. Epub 2019 Jul 4. Erratum in: Lancet. 2019 Jul 16;:.

PMID:
31280967
14.

Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors.

Weigt D, Parrish CA, Krueger JA, Oleykowski CA, Rendina AR, Hopf C.

Cell Chem Biol. 2019 Sep 19;26(9):1322-1331.e4. doi: 10.1016/j.chembiol.2019.06.004. Epub 2019 Jul 3.

PMID:
31279605
15.

IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.

Callewaert C, Nakatsuji T, Knight R, Kosciolek T, Vrbanac A, Kotol P, Ardeleanu M, Hultsch T, Guttman-Yassky E, Bissonnette R, Silverberg JI, Krueger J, Menter A, Graham NMH, Pirozzi G, Hamilton JD, Gallo RL.

J Invest Dermatol. 2019 Jun 25. pii: S0022-202X(19)31789-0. doi: 10.1016/j.jid.2019.05.024. [Epub ahead of print]

16.

Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.

Frew JW, Navrazhina K, Marohn M, Lu PC, Krueger JG.

Exp Dermatol. 2019 Aug;28(8):886-891. doi: 10.1111/exd.13978. Epub 2019 Jul 3.

PMID:
31140657
17.

IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.

Krueger JG, Wharton KA Jr, Schlitt T, Suprun M, Torene RI, Jiang X, Wang CQ, Fuentes-Duculan J, Hartmann N, Peters T, Koroleva I, Hillenbrand R, Letzkus M, Yu X, Li Y, Glueck A, Hasselberg A, Flannery B, Suárez-Fariñas M, Hueber W.

J Allergy Clin Immunol. 2019 Sep;144(3):750-763. doi: 10.1016/j.jaci.2019.04.029. Epub 2019 May 24.

18.

Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.

Zirngibl RA, Wang A, Yao Y, Manolson MF, Krueger J, Dupuis L, Mendoza-Londono R, Voronov I.

J Cell Biochem. 2019 Oct;120(10):17180-17193. doi: 10.1002/jcb.28979. Epub 2019 May 20.

PMID:
31111556
19.

The neuron-specific interleukin-1 receptor accessory protein alters emergent network state properties in Vitro.

Nguyen JT, Sahabandu D, Taishi P, Xue M, Jewett K, Dykstra-Aiello C, Roy S, Krueger JM.

Neurobiol Sleep Circadian Rhythms. 2019 Jan;6:35-43. doi: 10.1016/j.nbscr.2019.01.002. Epub 2019 Jan 18.

20.

Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals.

Del Duca E, Pavel AB, Dubin C, Song T, Wallace EB, Peng X, Estrada YD, Xu H, Maari C, Jack C, St-Cyr Proulx E, Krueger JG, Bissonnette R, Guttman-Yassky E.

J Invest Dermatol. 2019 Oct;139(10):2228-2232.e10. doi: 10.1016/j.jid.2019.04.008. Epub 2019 May 3. No abstract available.

PMID:
31059695
21.

Small-Angle Scattering as a Structural Probe for Nucleic Acid Nanoparticles (NANPs) in a Dynamic Solution Environment.

Oliver RC, Rolband LA, Hutchinson-Lundy AM, Afonin KA, Krueger JK.

Nanomaterials (Basel). 2019 May 2;9(5). pii: E681. doi: 10.3390/nano9050681. Review.

22.

The yield of monitoring adenovirus in pediatric hematopoietic stem cell transplant patients.

Ali S, Krueger J, Richardson SE, Sung L, Waespe N, Renzi S, Chiang K, Allen U, Ali M, Schechter T.

Pediatr Hematol Oncol. 2019 Apr;36(3):161-172. doi: 10.1080/08880018.2019.1607961. Epub 2019 Apr 30.

PMID:
31037986
23.

The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease.

Brunner PM, He H, Pavel AB, Czarnowicki T, Lefferdink R, Erickson T, Canter T, Puar N, Rangel SM, Malik K, Estrada Y, Krueger JG, Guttman-Yassky E, Paller AS.

J Am Acad Dermatol. 2019 Aug;81(2):510-519. doi: 10.1016/j.jaad.2019.04.036. Epub 2019 Apr 19.

PMID:
31009665
24.

The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions.

Guttman-Yassky E, Zhou L, Krueger JG.

J Allergy Clin Immunol. 2019 Aug;144(2):362-374. doi: 10.1016/j.jaci.2019.03.021. Epub 2019 Apr 5.

25.

A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe psoriasis.

Svecova D, Lubell MW, Casset-Semanaz F, Mackenzie H, Grenningloh R, Krueger JG.

J Am Acad Dermatol. 2019 Jul;81(1):196-203. doi: 10.1016/j.jaad.2019.03.056. Epub 2019 Mar 27.

26.

Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms.

Frew JW, Hawkes JE, Krueger JG.

Ther Adv Chronic Dis. 2019 Mar 1;10:2040622319830646. doi: 10.1177/2040622319830646. eCollection 2019. Review.

27.

A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa.

Frew JW, Hawkes JE, Krueger JG.

F1000Res. 2018 Dec 13;7:1930. doi: 10.12688/f1000research.17267.1. eCollection 2018.

28.

Inflammasome Signaling and Impaired Vascular Health in Psoriasis.

Garshick MS, Barrett TJ, Wechter T, Azarchi S, Scher JU, Neimann A, Katz S, Fuentes-Duculan J, Cannizzaro MV, Jelic S, Fisher EA, Krueger JG, Berger JS.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):787-798. doi: 10.1161/ATVBAHA.118.312246.

PMID:
30760013
29.

Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.

Alsuwaidan A, Pirruccello E, Jaso J, Koduru P, Garcia R, Krueger J, Doucet M, Chaudhry R, Fuda F, Chen W.

Cytometry B Clin Cytom. 2019 Sep;96(5):368-374. doi: 10.1002/cyto.b.21770. Epub 2019 Feb 7.

PMID:
30734478
30.

Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept.

Brodmerkel C, Li K, Garcet S, Hayden K, Chiricozzi A, Novitskaya I, Fuentes-Duculan J, Suarez-Farinas M, Campbell K, Krueger JG.

J Allergy Clin Immunol. 2019 May;143(5):1965-1969. doi: 10.1016/j.jaci.2019.01.017. Epub 2019 Jan 29. No abstract available.

31.

Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa.

Frew JW, Hawkes JE, Sullivan-Whalen M, Gilleaudeau P, Krueger JG.

Br J Dermatol. 2019 Sep;181(3):566-571. doi: 10.1111/bjd.17695. Epub 2019 Apr 19.

PMID:
30693478
32.

Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis.

Zhou L, Leonard A, Pavel AB, Malik K, Raja A, Glickman J, Estrada YD, Peng X, Del Duca E, Sanz-Cabanillas J, Ruano J, Xu H, Zhang N, Wen HC, Gonzalez J, Garcet S, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2019 Jul;144(1):144-156. doi: 10.1016/j.jaci.2019.01.015. Epub 2019 Jan 24.

PMID:
30685456
33.

Hyperspectral imaging in automated digital dermoscopy screening for melanoma.

Hosking AM, Coakley BJ, Chang D, Talebi-Liasi F, Lish S, Lee SW, Zong AM, Moore I, Browning J, Jacques SL, Krueger JG, Kelly KM, Linden KG, Gareau DS.

Lasers Surg Med. 2019 Mar;51(3):214-222. doi: 10.1002/lsm.23055. Epub 2019 Jan 17.

34.

Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1.

Ernst D, Williams BA, Wang XH, Yoon N, Kim KP, Chiu J, Luo ZJ, Hermans KG, Krueger J, Keating A.

Blood Cancer J. 2019 Jan 15;9(2):6. doi: 10.1038/s41408-018-0168-2.

35.

Identification and Quantification of (t)RNA Modifications in Pseudomonas aeruginosa by Liquid Chromatography-Tandem Mass Spectrometry.

Grobe S, Doberenz S, Ferreira K, Krueger J, Brönstrup M, Kaever V, Häussler S.

Chembiochem. 2019 Jun 3;20(11):1430-1437. doi: 10.1002/cbic.201800741. Epub 2019 Apr 5.

PMID:
30644616
36.

Atopic dermatitis endotypes and implications for targeted therapeutics.

Czarnowicki T, He H, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2019 Jan;143(1):1-11. doi: 10.1016/j.jaci.2018.10.032. Review.

PMID:
30612663
37.

On Surprise-Hacking.

Felin T, Felin M, Krueger JI, Koenderink J.

Perception. 2019 Feb;48(2):109-114. doi: 10.1177/0301006618822217. Epub 2019 Jan 3. No abstract available.

PMID:
30606069
38.

Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab.

Visvanathan S, Baum P, Vinisko R, Schmid R, Flack M, Lalovic B, Kleiner O, Fuentes-Duculan J, Garcet S, Davis JW, Grebe KM, Fine JS, Padula SJ, Krueger JG.

J Allergy Clin Immunol. 2019 Jun;143(6):2158-2169. doi: 10.1016/j.jaci.2018.11.042. Epub 2018 Dec 20.

39.

Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases.

Czarnowicki T, He H, Leonard A, Kim HJ, Kameyama N, Pavel AB, Li R, Estrada Y, Wen HC, Kimmel GW, Kim HJ, Chima M, Lebwohl M, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2019 Jun;143(6):2095-2107. doi: 10.1016/j.jaci.2018.11.031. Epub 2018 Dec 18.

PMID:
30576756
40.

From Wide Cognition to Mechanisms: A Silent Revolution.

Miłkowski M, Clowes R, Rucińska Z, Przegalińska A, Zawidzki T, Krueger J, Gies A, McGann M, Afeltowicz Ł, Wachowski W, Stjernberg F, Loughlin V, Hohol M.

Front Psychol. 2018 Dec 6;9:2393. doi: 10.3389/fpsyg.2018.02393. eCollection 2018.

41.

Structure and function of dual-source cholinergic modulation in early vision.

Krueger J, Disney AA.

J Comp Neurol. 2019 Feb 15;527(3):738-750. doi: 10.1002/cne.24590. Epub 2018 Dec 20. Review.

PMID:
30520037
42.

Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients.

Brunner PM, Israel A, Leonard A, Pavel AB, Kim HJ, Zhang N, Czarnowicki T, Patel K, Murphrey M, Ramsey K, Rangel S, Zebda R, Soundararajan V, Zheng X, Estrada YD, Xu H, Krueger JG, Paller AS, Guttman-Yassky E.

Ann Allergy Asthma Immunol. 2019 Mar;122(3):318-330.e3. doi: 10.1016/j.anai.2018.11.025. Epub 2018 Dec 1.

PMID:
30508584
43.

Local sleep.

Krueger JM, Nguyen JT, Dykstra-Aiello CJ, Taishi P.

Sleep Med Rev. 2019 Feb;43:14-21. doi: 10.1016/j.smrv.2018.10.001. Epub 2018 Nov 12. Review.

44.

Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.

Ali S, AlThubaiti S, Renzi S, Krueger J, Chiang KY, Naqvi A, Schechter T, Punnett A, Ali M.

Pediatr Transplant. 2019 Feb;23(1):e13319. doi: 10.1111/petr.13319. Epub 2018 Nov 11.

PMID:
30417487
45.

Collection of hematopoietic stem cells and immune effector cells in small children.

Empringham B, Chiang KY, Krueger J.

Transfus Apher Sci. 2018 Oct;57(5):614-618. doi: 10.1016/j.transci.2018.10.004. Epub 2018 Oct 24. Review.

PMID:
30385106
46.

Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.

Yan BY, Garcet S, Gulati N, Kiecker F, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen M, Shemer A, Mitsui H, Krueger JG.

Exp Dermatol. 2019 Jan;28(1):35-44. doi: 10.1111/exd.13805. Epub 2018 Dec 21.

PMID:
30326165
47.

The Harasser's Toolbox: Investigating the Role of Mobility in Street Harassment.

Hutson ACF, Krueger JC.

Violence Against Women. 2019 May;25(7):767-791. doi: 10.1177/1077801218804100. Epub 2018 Oct 15.

PMID:
30319050
48.

Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.

Patel NP, Vukmanovic-Stejic M, Suarez-Farinas M, Chambers ES, Sandhu D, Fuentes-Duculan J, Mabbott NA, Rustin MHA, Krueger J, Akbar AN.

J Infect Dis. 2018 Sep 22;218(suppl_2):S88-S98. doi: 10.1093/infdis/jiy420.

49.

Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation.

Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N, Cueto I, Peng X, Estrada Y, Fuentes-Duculan J, Alexis AF, Krueger JG, Guttman-Yassky E.

Ann Allergy Asthma Immunol. 2019 Jan;122(1):99-110.e6. doi: 10.1016/j.anai.2018.08.024. Epub 2018 Sep 14.

PMID:
30223113
50.

Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?

Susnik B, Schneider L, Swenson KK, Krueger J, Braatz C, Lillemoe T, Tsai M, DeFor TE, Knaack M, Rueth N.

J Surg Oncol. 2018 Jul;118(1):221-227. doi: 10.1002/jso.25130. Epub 2018 Sep 9.

PMID:
30196538

Supplemental Content

Loading ...
Support Center